Cargando…
Severe Cytomegalovirus Gastritis During Natalizumab-Mediated Immunosuppression
We report a 35-year-old female receiving natalizumab as monotherapy for multiple sclerosis who subsequently developed severe cytomegalovirus gastritis. As cytomegalovirus gastritis has not been previously described during natalizumab treatment, we discuss the biological plausibility of this potentia...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Gastroenterology
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356152/ https://www.ncbi.nlm.nih.gov/pubmed/28331881 http://dx.doi.org/10.14309/crj.2017.43 |